Last reviewed · How we verify

Insulin treatment for hyperglycemia

University of Michigan · FDA-approved active Small molecule

Insulin treatment for hyperglycemia is a Insulin Small molecule drug developed by University of Michigan. It is currently FDA-approved for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Hyperglycemia in hospitalized patients.

Insulin replaces or supplements the body's own insulin to lower blood glucose by promoting glucose uptake into cells and storage as glycogen.

Insulin replaces or supplements the body's own insulin to lower blood glucose by promoting glucose uptake into cells and storage as glycogen. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Hyperglycemia in hospitalized patients.

At a glance

Generic nameInsulin treatment for hyperglycemia
SponsorUniversity of Michigan
Drug classInsulin
TargetInsulin receptor
ModalitySmall molecule
Therapeutic areaEndocrinology / Diabetes
PhaseFDA-approved

Mechanism of action

Insulin is a hormone that binds to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport from the bloodstream into these tissues for energy use or storage. This reduces circulating blood glucose levels in hyperglycemic patients. Insulin also suppresses hepatic glucose production and promotes anabolic processes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Insulin treatment for hyperglycemia

What is Insulin treatment for hyperglycemia?

Insulin treatment for hyperglycemia is a Insulin drug developed by University of Michigan, indicated for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Hyperglycemia in hospitalized patients.

How does Insulin treatment for hyperglycemia work?

Insulin replaces or supplements the body's own insulin to lower blood glucose by promoting glucose uptake into cells and storage as glycogen.

What is Insulin treatment for hyperglycemia used for?

Insulin treatment for hyperglycemia is indicated for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Hyperglycemia in hospitalized patients.

Who makes Insulin treatment for hyperglycemia?

Insulin treatment for hyperglycemia is developed and marketed by University of Michigan (see full University of Michigan pipeline at /company/university-of-michigan).

What drug class is Insulin treatment for hyperglycemia in?

Insulin treatment for hyperglycemia belongs to the Insulin class. See all Insulin drugs at /class/insulin.

What development phase is Insulin treatment for hyperglycemia in?

Insulin treatment for hyperglycemia is FDA-approved (marketed).

What are the side effects of Insulin treatment for hyperglycemia?

Common side effects of Insulin treatment for hyperglycemia include Hypoglycemia, Weight gain, Injection site reactions, Lipodystrophy.

What does Insulin treatment for hyperglycemia target?

Insulin treatment for hyperglycemia targets Insulin receptor and is a Insulin.

Related